Aspirin maker Novacap debuts in HY with €310m floater

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Aspirin maker Novacap debuts in HY with €310m floater

Novacap, the French chemicals group owned by Ardian, made its high yield bond market debut on Thursday with a €310m floating rate note that was priced at the tight end of guidance.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article